{"product_id":"9781441976208","title":"Ophthalmologic Drug Guide","description":"\u003cp\u003eDrug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have become increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink\/white for steroid drops, grey for topical NSAIDS, etc.). There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry-eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.\u003c\/p\u003e","brand":"Springer New York","offers":[{"title":"Default Title","offer_id":47059509903600,"sku":"9781441976208","price":69.99,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/9781441976208_p0.jpg?v=1763796036","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/9781441976208","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}